Nonalcoholic fatty liver disease in HIV-infected persons: epidemiology and the role of nucleoside reverse transcriptase inhibitors

J Acquir Immune Defic Syndr. 2010 Feb;53(2):278; author reply 278-81. doi: 10.1097/QAI.0b013e3181c990ed.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Biopsy
  • Drug Administration Schedule
  • Fatty Liver / chemically induced*
  • Fatty Liver / pathology
  • Female
  • HIV Infections / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Reverse Transcriptase Inhibitors / adverse effects*
  • Risk Factors

Substances

  • Reverse Transcriptase Inhibitors